MN HF511

Expands "face-to-face" definition to include telemedicine services delivered via electronic combined audio and visual communication for substance use disorder and mental health treatment.

Allows comprehensive substance use disorder assessments to be conducted via telemedicine in addition to in-person, with assessments required within 3 calendar days for residential programs or within 3 days of treatment sessions for nonresidential programs.

Permits alcohol and drug counselors to document verbal approval of treatment plans via telemedicine in lieu of written signatures when clients receive services or assessments through telemedicine.

Allows chemical use assessments to be conducted via telemedicine including two-way interactive video or telephone communication, notwithstanding existing rules.

Extends telemedicine coverage for substance use disorder and mental health services at same reimbursement rates as in-person services, effective January 1, 2022, pending federal approval, and repeals opioid treatment program outreach requirements.